AstraZeneca Plc - Company Snapshot & SWOT Analysis

Publication ID:

NAV0619001

Publication Date:

June 5, 2019

Pages:

Publisher:

NAVADHI

USD 200.00

Pharma & Healthcare [1]

Company Reports (Pharma & Healthcare) [2]

Description:

As per NAVADHI Market Research, the听global pharmaceutical industry [3]听will we worth听USD 1.57 trillion听by 2023.

ASTRAZENECA PLC Financial Review

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular & Metabolic Disease (CVMD) and Respiratory.

AstraZeneca reported revenue of USD 22.090 billion for the FY 2018 which saw an increase of 1.67% compared to FY 2017. This revenue is expected to increase by 6% and reach USD 23.415 billion by FY 2019. AstraZeneca revenue decreased at a CAGR of 2.99% during FY 2013 to FY 2018.

AstraZeneca registered the highest revenue from Cardiovascular, Renal, and Metabolism therapy area at USD 6.710 billion which accounted for 31.88% of its total sales in FY 2018. In FY 2018, AstraZeneca registered the highest revenue from the United States market at USD 7.24 billion which accounted for 32.78% of its total sales in FY 2018. This was followed by China with revenue of USD 3.778 billion accounting for 17.10% of total FY 2018 sales and United Kingdom with revenue of USD 2.39 billion and accounting for 10.82% of total FY 2018 sales.

Scope of the AstraZeneca PLC - Company Snapshot & SWOT Analysis Report

鈥⑻� 听This report provides detailed information about AstraZeneca PLC including value chain analysis, financial performance, business strategy, and SWOT analysis.
鈥⑻� 听The report identifies the growth drivers and inhibitors for the global pharmaceutical market.
鈥⑻� 听This report provides information about current and future trends for the global pharmaceutical market.听

Table Of Contents:

1. Executive Summary

Scope of the AstraZeneca PLC - Company Snapshot & SWOT Analysis Report听听听
Research Methodology

2. Growth Drivers and Inhibitors for Global Pharmaceuticals Market
3. Company Profile
3.1 AstraZeneca PLC
3.1.1 Company Profile
3.1.2 AstraZeneca PLC in Global Pharmaceuticals Manufacturing Value Chain
3.1.3 AstraZeneca PLC: Financial Performance
3.1.3.1 AstraZeneca PLC: Overall Revenue FY 2013-FY 2019 (in USD billion)
3.1.3.2 AstraZeneca PLC: Geography-Wise Revenue FY 2018 (in USD billion)
3.1.3.3 AstraZeneca PLC: Therapy Area-Wise Revenue FY 2018 (in USD billion)
3.1.4 AstraZeneca PLC: Business Strategy
3.1.4.1 Product Level Strategy
3.1.5 SWOT Analysis of AstraZeneca Plc

Strengths
Weaknesses
Opportunities
Threats

4. Current and Future Trends in Pharmaceutical Market

Orphan Drugs
Biologics and Biosimilars

Current Trends
1. Increasing Severity of Drug Price Controls
2. Greater Focus on Rare Diseases / Orphan Drugs
3. Increasing Development of Nucleic Acids as Therapeutics
4. Increasing Focus on Cell Therapy
5. Implantables (Bioelectronics) and Electroceuticals are Expected to Become Mainstream
6. Use of 3D Printing to Reduce Cost and Improve Production Efficiency of Biologics
7. Increasing Use of Big Data and Artificial Intelligence (AI) in Drug Discovery

List of Exhibits
Notes
Company Information

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂